Published in Genes Dev on July 01, 2016
Disruption of CDK-resistant chromatin association by pRB causes DNA damage, mitotic errors, and reduces Condensin II recruitment. Cell Cycle (2017) 0.84
Novel functions for the transcription factor E2F4 in development and disease. Cell Cycle (2016) 0.76
RB localizes to DNA double-strand breaks and promotes DNA end resection and homologous recombination through the recruitment of BRG1. Genes Dev (2016) 0.76
DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways. Neoplasia (2017) 0.75
Regulation and Function of Cdt1; A Key Factor in Cell Proliferation and Genome Stability. Genes (Basel) (2016) 0.75
Switching on regeneration. Stem Cell Investig (2016) 0.75
Human cytomegalovirus-encoded viral cyclin-dependent kinase (v-CDK) UL97 phosphorylates and inactivates the retinoblastoma protein-related p107 and p130 proteins. J Biol Chem (2017) 0.75
Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells. Stem Cell Reports (2017) 0.75
MYC Modulation around the CDK2/p27/SKP2 Axis. Genes (Basel) (2017) 0.75
Intersection of retinoblastoma tumor suppressor function, stem cells, metabolism, and inflammation. Cancer Sci (2017) 0.75
A distinct function of the retinoblastoma protein in the control of lipid composition identified by lipidomic profiling. Oncogenesis (2017) 0.75
In Vitro Differentiation of Preosteoblast-Like Cells, MC3T3-E1, to Adipocytes Is Enhanced by 1,25(OH)2 Vitamin D3. Front Endocrinol (Lausanne) (2017) 0.75
Virus/Host Cell Crosstalk in Hypoxic HPV-Positive Cancer Cells. Viruses (2017) 0.75
Cancer cell cycles. Science (1996) 21.29
The retinoblastoma protein and cell cycle control. Cell (1995) 20.21
The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science (1989) 16.54
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature (1986) 13.96
SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell (1988) 12.69
Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature (1988) 10.98
Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell (1992) 7.61
Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev (1993) 7.40
Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science (1987) 6.93
Emerging landscape of oncogenic signatures across human cancers. Nat Genet (2013) 6.48
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer. N Engl J Med (2015) 6.38
The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev (2000) 5.93
Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther (2004) 5.69
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res (2009) 5.20
Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer (2008) 5.19
A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02
The Rb/E2F pathway and cancer. Hum Mol Genet (2001) 4.98
Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell (2011) 4.83
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78
Structural evidence for the authenticity of the human retinoblastoma gene. Science (1987) 4.67
Inactivation of the p53 pathway in retinoblastoma. Nature (2006) 4.57
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature (2004) 4.41
pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev (1997) 4.36
Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence. Cancer Cell (2010) 3.81
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (1995) 3.41
A common set of gene regulatory networks links metabolism and growth inhibition. Mol Cell (2004) 3.37
Cell-specific effects of RB or RB/p107 loss on retinal development implicate an intrinsically death-resistant cell-of-origin in retinoblastoma. Cancer Cell (2004) 3.17
Replication stress links structural and numerical cancer chromosomal instability. Nature (2013) 3.11
BNIP3 is an RB/E2F target gene required for hypoxia-induced autophagy. Mol Cell Biol (2007) 3.10
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med (2015) 2.95
The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. Mol Cell (2001) 2.93
Retinoblastoma has properties of a cone precursor tumor and depends upon cone-specific MDM2 signaling. Cell (2009) 2.79
Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat Cell Biol (2006) 2.60
Rb regulates fate choice and lineage commitment in vivo. Nature (2010) 2.60
Molecular mechanisms underlying RB protein function. Nat Rev Mol Cell Biol (2013) 2.58
Retinoblastoma protein partners. Adv Cancer Res (2001) 2.53
Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice. Nat Genet (1998) 2.53
Loss of pRB causes centromere dysfunction and chromosomal instability. Genes Dev (2010) 2.50
pRB plays an essential role in cell cycle arrest induced by DNA damage. Proc Natl Acad Sci U S A (1998) 2.49
The requirement for cyclin D function in tumor maintenance. Cancer Cell (2012) 2.49
Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal. Nature (2010) 2.36
Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell (2011) 2.29
Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase. Oncogene (2003) 2.22
Comprehensive genomic profiles of small cell lung cancer. Nature (2015) 2.20
The retinoblastoma tumor suppressor modifies the therapeutic response of breast cancer. J Clin Invest (2006) 2.18
Mitotic chromosome condensation mediated by the retinoblastoma protein is tumor-suppressive. Genes Dev (2010) 2.12
CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors. Cancer Cell (2014) 2.09
Acetylation control of the retinoblastoma tumour-suppressor protein. Nat Cell Biol (2001) 2.05
Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev (2008) 2.05
Phase I, dose-escalation trial of the oral cyclin-dependent kinase 4/6 inhibitor PD 0332991, administered using a 21-day schedule in patients with advanced cancer. Clin Cancer Res (2011) 2.03
Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. Genes Dev (1998) 1.99
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic response. Cell Cycle (2010) 1.96
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma. J Clin Oncol (2013) 1.94
Loss of Rb proteins causes genomic instability in the absence of mitogenic signaling. Genes Dev (2010) 1.88
Rb suppresses human cone-precursor-derived retinoblastoma tumours. Nature (2014) 1.83
pRB contains an E2F1-specific binding domain that allows E2F1-induced apoptosis to be regulated separately from other E2F activities. Mol Cell (2003) 1.77
Methylation of the retinoblastoma tumor suppressor by SMYD2. J Biol Chem (2010) 1.73
Proapoptotic function of the retinoblastoma tumor suppressor protein. Cancer Cell (2009) 1.73
The search for the retinoblastoma cell of origin. Nat Rev Cancer (2005) 1.72
E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol (2011) 1.70
Lysine methylation-dependent binding of 53BP1 to the pRb tumor suppressor. Proc Natl Acad Sci U S A (2014) 1.63
Skp2 is required for survival of aberrantly proliferating Rb1-deficient cells and for tumorigenesis in Rb1+/- mice. Nat Genet (2009) 1.62
Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. Nat Cell Biol (2015) 1.61
Suppression of genome instability in pRB-deficient cells by enhancement of chromosome cohesion. Mol Cell (2014) 1.58
Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidy. Cancer Discov (2014) 1.57
Tumor suppressor genes. Curr Opin Genet Dev (1994) 1.57
An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol Cell (2004) 1.55
Phosphorylation-induced conformational changes in the retinoblastoma protein inhibit E2F transactivation domain binding. J Biol Chem (2010) 1.54
RBF1 promotes chromatin condensation through a conserved interaction with the Condensin II protein dCAP-D3. Genes Dev (2008) 1.53
E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas. Mol Cell Biol (2003) 1.50
Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice. Mol Cell Biol (2005) 1.50
Loss of dE2F compromises mitochondrial function. Dev Cell (2013) 1.47
Deciphering the retinoblastoma protein phosphorylation code. Trends Biochem Sci (2012) 1.46
Loss of the retinoblastoma tumor suppressor: differential action on transcriptional programs related to cell cycle control and immune function. Oncogene (2007) 1.45
RB acute loss induces centrosome amplification and aneuploidy in murine primary fibroblasts. Mol Cancer (2006) 1.44
Specific killing of Rb mutant cancer cells by inactivating TSC2. Cancer Cell (2010) 1.42
The retinoblastoma tumor-suppressor gene, the exception that proves the rule. Oncogene (2006) 1.41
A novel Rb- and p300-binding protein inhibits transactivation by MyoD. Mol Cell Biol (2000) 1.40
Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia. Cancer Cell (2012) 1.40
Regulation of the PDK4 isozyme by the Rb-E2F1 complex. J Biol Chem (2008) 1.38
Structures of inactive retinoblastoma protein reveal multiple mechanisms for cell cycle control. Genes Dev (2012) 1.37
Developmental defects and tumor predisposition in Rb mutant mice. Oncogene (1999) 1.37
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer. Endocr Relat Cancer (2011) 1.35
Cells degrade a novel inhibitor of differentiation with E1A-like properties upon exiting the cell cycle. Mol Cell Biol (2000) 1.35
The retinoblastoma tumor suppressor and stem cell biology. Genes Dev (2012) 1.34
The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene (1997) 1.34
Chromosomal instability: a composite phenotype that influences sensitivity to chemotherapy. Cell Cycle (2009) 1.34
CENPA overexpression promotes genome instability in pRb-depleted human cells. Mol Cancer (2009) 1.31
CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment. Clin Cancer Res (2014) 1.31
Lysine methylation regulates the pRb tumour suppressor protein. Oncogene (2010) 1.30
Loss of RBF1 changes glutamine catabolism. Genes Dev (2013) 1.30
Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1. Proc Natl Acad Sci U S A (2011) 1.28
The retinoblastoma protein induces apoptosis directly at the mitochondria. Genes Dev (2013) 1.28
Targeting CDK4 and CDK6: From Discovery to Therapy. Cancer Discov (2015) 1.27
Acetylation regulates the differentiation-specific functions of the retinoblastoma protein. EMBO J (2004) 1.27
Distinct gene expression phenotypes of cells lacking Rb and Rb family members. Cancer Res (2003) 1.26
Cyclin D activates the Rb tumor suppressor by mono-phosphorylation. Elife (2014) 1.26
Control of glutamine metabolism by the tumor suppressor Rb. Oncogene (2013) 1.25